CODerm Research:  303.761.0906

(option 6)

Active Clinic Trials


(1) Atopic Dermatitis (Eczema)

Eczema doesn’t have to control your life. If you are struggling with the symptoms of moderate to severe atopic dermatitis, a study involving a once daily oral pill in combination with topical corticosteroids could be an option for you.

Qualified participants include:

  • Adolescents aged 12 to 17 years (minimum weight of 88 pounds)
  • Those with chronic moderate to severe symptoms that started at least 3 years from planned study start date
  • No prior Dupixent usage

Those that qualify will:

  • Receive study-related care from a board certified physician and other medical staff at no cost
  • Receive payment for each visit

(2) Atopic Dermatitis (Eczema)

Do you suffer from moderate to severe Atopic Dermatitis (Eczema)?  If so, you may qualify for a clinical trial studying the effectiveness of a once daily investigational oral pill for moderate to severe atopic dermatitis.

Qualified participants include:

  • Adults aged 18 and up

Those that qualify will:

  • Receive study treatment from a board certified dermatologist at no cost
  • Will be compensated for their time, per visit

(3) Atopic Dermatitis (Eczema)

Suffering from moderate to severe Atopic Dermatitis (Eczema)?
You may be eligible for a research trial studying the use of an investigational drug on moderate to severe eczema.

Qualified participants:

You may qualify if you:

  • Are at least 18 years of age
  • Have a diagnosis of moderate to severe atopic dermatitis (AD) with an onset of symptoms at least 2 years ago
  • Have tried topical steroids in the past to alleviate symptoms

Interested in participating in a clinical trial?

Please contact us at (303) 761-0906, option 6 or email us at with your name, phone number, date of birth and study of interest.


If you are interested in having CODerm running your study at our site please contact